<!doctype html><html><head><meta charset=utf-8><title>Vitamin D needed to treat Breast Cancer varied by 70X</title>
<link rel=stylesheet href="/css/main.css?v=1748382344"><link rel=stylesheet href="/css/pagination.css?v=1748382344"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src=https://unpkg.com/lunr/lunr.js></script><script src=https://cdn.jsdelivr.net/npm/pako@2.1.0/dist/pako.min.js></script><script src="/js/search.js?v=1748382344"></script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>Vitamin D needed to treat Breast Cancer varied by 70X</h1><time>March 29, 2024</time><ul><li><p><strong>Personalized Vitamin D dosing</strong> ranged from 2,000 IU to 140,000 weekly for Breast Cancer:</p><ul><li>A range of 70 to 1</li></ul></li><li><p>Treating healthy people typically requires a range of Vitamin D of only 4 to 1</p></li><li><p>The women getting Breast Cancer treatment were clearly not uniformly unhealthy</p></li></ul><blockquote></blockquote><ul><li><p>The study failed to note improvement in outcomes vs women not getting Vitamin D</p><ul><li>Shorter treatment durations, less chemo used, less recurrence</li></ul></li></ul><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#course-of-vitamin-d-levels-in-newly-diagnosed-non-metastatic-breast-cancer-patients-over-one-year-with-quarterly-controls-and-substitution>Course of Vitamin D Levels in Newly Diagnosed Non-Metastatic Breast Cancer Patients over One Year with Quarterly Controls and Substitution</a></li></ul></li></ul></li></ul></nav><hr><h4 id=course-of-vitamin-d-levels-in-newly-diagnosed-non-metastatic-breast-cancer-patients-over-one-year-with-quarterly-controls-and-substitution>Course of Vitamin D Levels in Newly Diagnosed Non-Metastatic Breast Cancer Patients over One Year with Quarterly Controls and Substitution</h4><p>Nutrients. 2024 Mar 15;16(6):854. <a href=https://doi.org/10.3390/nu16060854.>doi: 10.3390/nu16060854.</a></p><p>Cosima Zemlin 1 2, Laura Altmayer 1, Marina Lang 1, Julia Theresa Schleicher 1, Caroline Stuhlert 1, Carolin Wörmann 1, Laura-Sophie Scherer 1, Ida Clara Thul 1, Lisanne Sophie Spenner 1, Jana Alisa Simon 1, Alina Wind 1, Elisabeth Kaiser 3 4, Regine Weber 3 4, Sybelle Goedicke-Fritz 3 4, Gudrun Wagenpfeil 5, Michael Zemlin 3, Erich-Franz Solomayer 1, Jörg Reichrath 6, Carolin Müller 1 2 7</p><img src=https://d1bk1kqxc0sym.cloudfront.net/attachments/png/20k-weekly-bc.png alt=image width=600><p><img src=https://d1bk1kqxc0sym.cloudfront.net/attachments/png/bc-baseline.png alt=image width=350> <img src=https://d1bk1kqxc0sym.cloudfront.net/attachments/png/bc-12-months.png alt=image width=350></p><img src=https://d1bk1kqxc0sym.cloudfront.net/attachments/png/bc-12-months-table.png alt=image width=900><h5 id=apparently-they-adjusted-dosing-quarterly-goal-of-30-to-100-ng-used-2000-to-140000-iu-weekly>Apparently they adjusted dosing quarterly (goal of 30 to 100 ng): used 2,000 to 140,000 IU weekly</h5><p>Background: Vitamin D levels in patients remain inadequately understood, with research yielding inconsistent findings. Breast cancer patients, particularly due to oncological therapies, face an increased risk of osteopenia, which can be exacerbated by a vitamin D deficiency.</p><p>Methods: The prospective observational &ldquo;BEGYN-1&rdquo; study assessed serum 25(OH D levels at baseline and quarterly thereafter. Clinical, pathological, nutritional, vitamin supplementation, and lifestyle data were recorded.</p><p>Results: Before treatment, 68.5% of patients were vitamin D deficient (&lt;30 ng/mL), with 4.6% experiencing severe deficiency (&lt;10 ng/mL). The median baseline 25(OH)D levels were 24 ng/mL (range: 4.8 to 64.7 ng/mL). Throughout the study, the median vitamin D levels increased to 48 ng/mL (range: 22.0 to 76.7 ng/mL). Before diagnosis, 16.7% received vitamin D substitution, and 97.8% received vitamin D substitution throughout the year with a median weekly dose of 20,000 IU. It took at least three quarterly assessments for 95% of patients to reach the normal range. A multiple GEE analysis identified associations between 25(OH)D levels and supplementation, season, age, VLDL, magnesium levels, and endocrine therapy.</p><p>Conclusions: Physicians should monitor 25(OH)D levels before, during, and after oncological therapy to prevent vitamin D deficiency and to adjust substitution individually. While variables such as seasons, age, VLDL, magnesium, diet, and oncological interventions affect 25(OH)D levels, supplementation has the greatest impact.</p><p><strong><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/bc-20k-weekly-average-compresspdf.pdf>Download the PDF from VitaminDWiki</a></strong></p></article></div></div><script src="/js/lightspa.js?v=1748382345"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1748382345",indexUrl:"/search/search_index.json.gz?v=1748382345"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1748382345"></script><script src="/js/search-results-panel.js?v=1748382345"></script><script src="/js/tiki-redirects.js?v=1748382345"></script></body></html>